2.0
Jan 30, 2024
Former employee, more than 1 year
East Greenbush, NY
Recommend
CEO approval
Business outlook
Pros
Good Work-life balance, decent middle management.
Cons
Senior leadership does not always have best interest in mind for employees. No hybrid/WFH opportunities. Expect to be underpaid by 20-25% when compared to similar positions at other larger pharma companies. Compensation is not performance-based.